X
+ Watchlist
Janus Henderson Global Life Sciences Fund
JNGLX:US
NASDAQ GM
56.89
USD
0.13
0.23%
As of 4/25/2018
Fund Type
Open-End Fund
52Wk Range
50.67 - 60.67
1 Yr Return
12.26%
YTD Return
3.85%
Previous Close
56.76
52Wk Range
50.67 - 60.67
1 Yr Return
12.67%
YTD Return
3.85%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/25/2018)
56.89
Total Assets (b USD) (on 03/30/2018)
3.563
Inception Date
12/31/1998
Last Dividend (on 12/19/2017)
0.204495
Dividend Indicated Gross Yield
0.36%
Fund Managers
ETHAN T LOVELL / ANDY ACKER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
2.00%
12b-1 Fee
0.00%
Current Mgmt Fee
0.64%
Expense Ratio
0.85%
Top Fund Holdings
Name | Position | Value | % of Fund |
---|---|---|---|
AET:US Aetna Inc | 655.17 k | 118.19 m | 3.31 |
AZN:LN AstraZeneca PLC | 1.67 m | 114.83 m | 3.21 |
LLY:US Eli Lilly & Co | 1.26 m | 106.20 m | 2.97 |
SHPG:US Shire PLC | 670.01 k | 103.93 m | 2.91 |
SAN:FP Sanofi | 1.18 m | 101.99 m | 2.85 |
CELG:US Celgene Corp | 876.86 k | 91.51 m | 2.56 |
HUM:US Humana Inc | 328.98 k | 81.61 m | 2.28 |
BIIB:US Biogen Inc | 248.69 k | 79.23 m | 2.22 |
ANTM:US Anthem Inc | 350.92 k | 78.96 m | 2.21 |
NVS:US Novartis AG | 937.26 k | 78.69 m | 2.20 |
Profile
Janus Henderson Global Life Sciences Fund seeks long-term growth of capital by investing in equity securities of U.S. and foreign companies, selected for their growth potential, that the manager believes have a life science orientation. The portfolio managers apply a "bottom up" approach in choosing investments.
Address
Janus Funds151 Detroit Street
Denver, CO 80206-4805
Phone
1-303-333-3863 Website
-